Journal of Shahrekord University of Medical Sciences

Author Guidelines

Electronic submission: Submission is only acceptable online at URL:

Terms of submission

Unsolicited manuscripts will be reviewed for publication with the following understanding:

1. The paper represents an original work.

2. The paper neither has already been published in another journal nor is being reviewed for publication with another journal.

3. Upon acceptance, the paper should not be published elsewhere without the permission of the Journal of Shahrekord University of Medical Sciences (JSUMS).

4. The published paper is the sole property of JSUMS and may be edited before publication.

Manuscripts should be submitted by one of the authors of the manuscript through the online system  ( The submitting author is responsible for ensuring that the article's publication has been approved by all the other coauthors. It is also the authors' responsibility to ensure that the articles derived from a particular institution-based research project are submitted with the necessary approval of the institution. The submitting author holds responsibility for the paper during submission and peer review.

Correspondence and proofs will be sent to the author(s) before publication unless otherwise indicated. The publication of a paper after provisional acceptance is subject to the authors’ permission for editing of the paper to enhance its readability. All enquiries concerning the publication of accepted papers should be sent to If online submission is not possible for some technical reasons, the author can contact for support.

All manuscripts are subject to peer review and are expected to meet the standards of academic excellence. Submissions will be considered by technical editor and section editor and “if not rejected right away” by peer-reviewers,

Article Processing Charge

JSUMS is an open access and quarterly journal, and authors and readers are not required to pay any fee for publication or otherwise.

Withdrawal Policy for authors

Authors are free to withdraw an article at no charge – as long as it is withdrawn within 7 days of its initial submission.

If you have concerns or questions about it, please contact us for further explanations. We welcome your input.


Units of measurement should be presented simply and concisely using System International (SI) units.

Types of Articles

Manuscripts should be presented as one of the following formats.

Full Original Researches

A full length original research article (up to ~5000 words, including tables, figures and references) presents novel findings relevant to the aims and scope of the journal.


A full length critical review (up to ~8000 words, including tables, figures and references) provides an abstract and discussion of the relevant literature about any topic covered within the aims and scope of the journal. Review articles should be provided an concise material and methods, sharply focused, well-focused, well-documented examinations of timely related issues.


Mini Reviews are sharply focused, well-focused, well-documented examinations of timely related issues (up to ~4000 words, including tables, figures and references). The issues may be of a controversial nature, or may address a more narrowly focused area than those typically covered in a review.

Short Communications

The Journal of Shahrekord University of Medical Sciences has updated the guidelines for preparing Short Communication. The updated guidelines can be found in the Guide for Authors, but for a short overview, please see below:

Short Communications are short articles that aim to rapidly disseminate original and significant material. For example, a Short Communication may highlight a particular dimension of a problem or a novel observation that may have a particular importance. Short articles include, yet are not limited to: development or discovery of new materials, innovation in simulation and modeling, pioneering experiments and theories, and clarification of mechanisms. As Short Communications have special effect on the field rather than report on incremental research, they will be given priority and be published as soon as possible.

Short Communications should not exceed 3000 words and are not subdivided. The paper should include an abstract, main body and (at least 8 and at most 15) references, and contain no more than 2 figures or tables, together. The abstract should not include more than 100 words. A guide on paper length is as follows:

The number of words for figures/tables/eqns is as follows as:

One column wide (7.5 cm) figures/tables: 20 words per cm height; two columns wide (15 cm) figures/tables: 40 words per cm height; equations: 20 words for each equation

Short Communications will appear at the end of the topical sections in the table of contents and begin with “Short Communication:” followed by the title.


Commentaries present the author’s considered opinion (up to ~1000 words limited to one figure/table and limited references) on an original article to be published in the journal and usually submitted by the reviewers.

Case reports

These reports should include introduction, case description, discussion and conclusions. Patient confidentiality must be maintained. Any identifying information must not be published, and any specific details or description that may compromise patient anonymity, should be omitted. The patient’s consent should be obtained when possible.

Letters to Editor

Letter to Editor presents the author’s opinion (up to ~1000 words limited to one figure/table with limited references). If such a letter criticizes an article already published in the journal, then the authors of the original article will be given a chance to respond in the same issue in which the letter is published.

Preparation of Manuscripts


Submitted manuscripts to JSUMS must be in DOC format with Times New Roman, size 12 and double spaced. Authors are strongly recommended to consult a recently published article in this journal and consider the following instructions.

Title page

Article Types: Original Article, Review Article, Short Communication, Letter to Editor, Viewpoint, etc.

Title: Lengthy systematic names and complicated/numerous chemical formulae should be avoided where possible.

Running title: A short running title (short title) of no more than 40 characters (including spaces) in length should be given.

Authors’ names: Full names (First, Middle and Last) for all the authors of an article should be given and specified with superscript number(s) for the affiliation(s) [e.g., Mark Junior Smiths1]. The name of the corresponding author(s) should be specified with an asterisk after name (e.g., Mark Junior Smiths*). Where the family name may be ambiguous (e.g., a double name), please indicate this clearly. In addition, affiliation of all the authors should be given and specified with superscripted number before address (e.g.,Faculty of …..). Authors' names should be written as follows:

Name of the Author

Affiliation: Department, School, University, Town, Country.


Corresponding author: Full address, telephone and fax numbers (with country and area code) and E-mail of the corresponding author(s) should be given.

Abstract page

Abstract: A factual concise abstract (Max 250 words) is required for every manuscript.

An abstract is often presented separately from the article; hence it must be able to stand alone. Referencing should be avoided. Also, non-standard or uncommon abbreviations should be avoided; however, if essential they must be defined at their first mention in the abstract itself.

Key words: Immediately after the abstract, three to six relevant keywords should be included. (Notice: Readers are increasingly used search engines to find literature using keywords; thus, recognizable and searchable keywords should be given to maximize the visibility of the article.)

Use terms from the Medical Subject Headings (MeSH) list of index medicus. Care must be taken to ensure that the abstract reflects the content of the article accurately.

Notice: Original research papers can also be published in a brief format. Submitted papers that are of interest but are not acceptable as a full-length original contribution are offered by the editor to be published in this section. Also, the authors can primarily submit their papers for consideration of publication in this section. An unstructured abstract not longer than 200 words is required for this section. The body of the manuscript should not exceed 2000 words, and no heading or subheading should be used. Tables and/or Figures should be up to 2 ones and references to 15 in maximum.


This section should clearly and briefly (up to 600 words) provide an adequate background with relevant references, avoiding a detailed literature survey or a summary of the results. The last paragraph should address the main objectives of the work.

Materials and Methods (Patients and Methods for clinical investigations)

This section should provide sufficient details to allow the work to be reproduced, with details of supplier (i.e., company’s name, city, country) and catalogue number when appropriate. Methods already published, should be indicated by a reference: only relevant modifications should be described. The company’s name, city and country of manufacturer of the major equipment should be given. Unexpected hazards encountered during the experimental work should be noted. Any unusual hazards inherent in the use of chemicals, procedures or equipments in the investigation should be clearly identified. In cases where a study involves the use of live animals or human subjects, the author should include a statement that all experiments were performed in compliance with the relevant laws and institutional guidelines, and also state the institutional committee(s) that has approved the experiments. They should also include a statement that informed consent was obtained for any experimentation with human subjects.


Results should be clear, descriptive and concise. Attention should be paid to the matter of significant figures and tables. The same data should not be presented in more than one figure or in both a figure and a table. Basically, as a rule, interpretation of the results should be reserved for the discussion section of a full original research article.


The discussion should explore the significance of the results of the work (without repeating them) in comparison with other similar studies. Extensive citations and discussion of published literature should be avoided.


The main question of the work should be very concisely stated and the final conclusions of the study should be presented in a short “Conclusions” section, which may stand alone or be a subsection of the Discussion section (s). 


Authors are responsible for the accuracy of all references that should be numbered sequentially in order of their appearance and the numbers of references should be parenthesized in the text. References should be numbered within the text. The references should be listed in a separate section following the text, double-spaced. All authors and inclusive page numbers should be limited to published works; unpublished data or personal communications should be indicated parenthetically in the text.

The references should be up-to-date and should be published within the past 5 years.

All references must follow the Vancouver style including the following items:

Numbered references should appear at the end of the article and consist of surnames and initials of all authors when six or less; otherwise, list the first six and then add et al. The title of the article, the name of the journal, the year of publication, the volume number (issue number), and the first page number-last page number should also be given.

Authors. Title. Journal name (Abbreviated according to the MEDLINE). Year; Volume (Issue): first page number-last page number.

Notice: For the standardized abbreviations of the names of the journals that are not indexed in the MEDLINE, refer to the ISSN List of Title Word Abbreviations available at:


Larkin J, Chiarion-Sileni V, Gonzalez R, Grob JJ, Cowey CL, Lao CD, et al. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma. N Engl J Med. 2015;373(1):23-34.

For books, names and initials of all authors, the full title, place of publication, publisher, thr year of publication, and page numbers should be given.

Authors. Title. Place of publication: Publisher; Year. (pp. Page Numbers of Chapter).


Tables should be prepared by a word processor's facility and saved in either DOC or RTF format.


The figures must have a resolution of at least 300 dpi at full size (when published in the journal).

Notice: Please insert figures and tables into the manuscript and ensure that each table and figure is mentioned in the text (e.g., Figure 1)

Ethical Issues

Please see the ethical issue provided in the below link

Every experimental or clinical study may raise controversial ethical issues (e.g., Institutional Ethical Approval for working with animal or human subjects). Thus, JSUMS expects all authors, reviewers and editors to consider COPE (Committee on Publication Ethics)ICMJE and Equator Network’s reporting guidelines in medical ethics plus scientific writing. If any, authors should state related declaration(s), otherwise the following sentence should be given “None to be declared". Please see the review process in JSUMS. 

The cover letter must include a statement declaring that the study complies with current ethical considerations.

Ethical issues (including plagiarism, misconduct, data fabrication, falsification, duplicate or redundant publication) must be completely considered by the authors.

Authors reporting experimental studies on human subjects must include a statement of assurance in the “Materials and Methods” of the manuscript reading that: (1) informed consent was obtained from each patient enrolled in the study and (2) the study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a priori approval by the institution's human research committee. In studies involving animal experimentation, provide assurance that all animals received humane care according to the criteria outlined in the "Guide for the Care and Use of Laboratory Animals" prepared by the National Academy of Sciences and published by the National Institutes of Health (NIH publication 86-23 revised 1985).

Please take a look at the following guidelines provided by COPE for editors and reviewers that may be helpful for authors, too:

Ethical considerations

In addition, the institutional ethics code ((for all type of studies)) or IRCT (Iranian Registry Clinical Trial), if applicable, should be written in the “Materials and Methods” section.

Human subjects

Authors reporting experimental studies on human subjects must include a statement of assurance in the Materials and Methods section of the manuscript reading that, the project was done with consideration of ethical issues and obtaining license from the ethics committee of local university/research center and obtaining the written consent of participants. Also, it was done according to ethical standards of human experimentation in accordance to the 1975 Helsinki Declaration.

Animal subjects

Authors reporting experimental studies on animal subjects must include a statement of assurance in the “Materials and Methods” section of the manuscript reading that, the project was done with consideration of ethical issues and obtaining license from the ethics committee of local institute. Besides, it should be mentioned that the general care of the experimental animals used for this study was received humane care according to the criteria outlined in the "Guide for the Care and Use of Laboratory Animals".

Informed Consent

In the case of research on human subjects, informed consent and other ethical considerations should be mentioned in the "Materials and Methods" section of the manuscript. The author should include a statement that informed consent was obtained for any experimentation with human subjects. As JHP follows ICMJE, please consider their guideline for more information. In cases where a study involves the use of live animals or human subjects, the author should also include a statement that all experiments were performed in compliance with the relevant laws and institutional guidelines, and also state the institutional committee(s) that has/have approved the experiments. For more information, please see the templates:

Conflict of Interests

The authors must declare any conflict of interests of the authors very briefly in a separate paragraph at the end of the paper. All sources of funding should be declared. If the research has not been funded by any institution, the following sentence should be written in this section “Authors declare no conflict of interests”.

To prevent the information on potential conflict of interest for authors from being overlooked or misplaced, mention this information in the cover letter. Authors must identify any potential financial conflicts of interest before the review process begins. Declared conflict of interest will not automatically result in rejection of paper but the editors reserve the right to publish any declared conflict of interest alongside accepted. The following would generally be regarded as potential conflicts of interest:

1. Direct financial payment to an author for the research or manuscript production by the funder of a product or service evaluated in the research.

2. Ownership of shares by an author in the company sponsoring a product service evaluated in an article (or in a company sponsoring a competing product).

3. Personal consultant for companies or other organizations with a financial interest in the promotion of particular health care products and services.

Source of Funding

 Authors are required to declare the source of funding for their research when submitting a paper. Suppliers of materials including their location (town, state/county, country) should also be mentioned. The information will be disclosed in the Acknowledgements section of the published article.

Copyright Assignment

If your paper is accepted, the author identified as the formal corresponding author for the paper, should study and sign the copyright statement, available on the journal website.


Authors should acknowledge any scientific, technical, statistical and financial supports. Contributors other than coauthors may be very briefly acknowledged in a separate paragraph at the end of the paper. All sources of funding should be declared.

In the Acknowledgements section, the code and the date of the approval of the research project from which the paper has been derived should be mentioned.


JSUMS will require an ORCID ID in the Scientific CV platform for all authors. To create your own ORCID ID, simply go to the ORCID website and register.

Additional Resources

Pleases download the additional resources for further consideration. These include:

  Download Original Article Word Template



  CAS (Chemical Abstract Services)






WHO EMRO | IMEMR | Library

The scientific journal "Internauka" is included in Index ...






Welcome to Research Directions


drji - 2nd International Conference on Innovative Research in ...


Magiran | بانک اطلاعات نشریات کشور


پایگاه اطلاعات علمی جهاد دانشگاهی